{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:22:42Z","timestamp":1783084962039,"version":"3.54.6"},"reference-count":39,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"abstract":"<jats:p>ABSTRACT Drug-resistant tuberculosis (TB) poses a significant threat, and drug-susceptibility testing (DST) is essential for effective TB treatment and control. Genotypic DST has been used for the early detection of drug-resistant TB, and the detection of isoniazid (INH) resistance is increasingly important. This study aims to determine the potential of genotypic DST using the AnyplexTM II MTB\/MDR real-time polymerase chain reaction (PCR) kit and analyze the mutations associated with INH and rifampicin (RIF) resistance in Mycobacterium tuberculosis (MTB). DST and DNA sequencing of the katG, inhA, and rpoB genes were performed in 146 MTB isolates. Compared with phenotypic DST, the Anyplex real-time PCR assay showed the sensitivity of 84.0%, 83.3%, 85.7%, and 94.6%; and the specificity of 96.9%, 96.4%, 98.2%, and 92.3% for the detection of INH resistance, RIF resistance, multidrug-resistant TB (MDR-TB), and drug-susceptible MTB, respectively. Substantial agreement with DNA sequencing was observed. For INH resistance, 91.8% had mutations in the katG or inhA; the katG gene accounted for 71.8%, and the inhA promoter region accounted for 20.0%. S315T was predominant in the katG mutation, and only C(-15)T was present in the inhA mutation. For RIF resistance, 95.1% harbored the rpoB mutation, with S531L and D516V being the two most common. The association of mutations with INH and RIF resistance was high. The study highlighted the significance of data on the genetic determinants of INH and RIF resistance, and suggested the potential of using genotypic DST, such as the Anyplex II MTB\/MDR assay, in the country and similar settings.<\/jats:p>","DOI":"10.1590\/s1678-9946202668040","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:55:04Z","timestamp":1783083304000},"source":"Crossref","is-referenced-by-count":0,"title":["The potential of molecular testing and mutation analysis for detecting isoniazid and rifampicin-resistant Mycobacterium tuberculosis in Thailand"],"prefix":"10.1590","volume":"68","author":[{"given":"Janisara","family":"Rudeeaneksin","sequence":"first","affiliation":[{"name":"Ministry of Public Health,  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-2898","authenticated-orcid":false,"given":"Benjawan","family":"Phetsuksiri","sequence":"additional","affiliation":[{"name":"Ministry of Public Health,  Thailand; Ministry of Public Health,  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopa","family":"Srisungngam","sequence":"additional","affiliation":[{"name":"Ministry of Public Health,  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supranee","family":"Bunchoo","sequence":"additional","affiliation":[{"name":"Ministry of Public Health,  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payu","family":"Bhakdeenuan","sequence":"additional","affiliation":[{"name":"Ministry of Public Health,  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiphat","family":"Klayut","sequence":"additional","affiliation":[{"name":"Ministry of Public Health,  Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","series-title":"Global tuberculosis report 2025","year":"2025"},{"key":"ref2","series-title":"Global tuberculosis report 2024","year":"2024"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3390\/pathogens13121045","article-title":"Strategies to enhance diagnostic capabilities for the new drug-resistant tuberculosis (DR-TB) drugs","volume":"13","author":"Saktiawati AM","year":"2024","journal-title":"Pathogens"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"100379","DOI":"10.1016\/j.jctube.2023.100379","article-title":"Prevalence of Mycobacterium tuberculosis mutations associated with isoniazid and rifampicin resistance: a systematic review and meta-analysis","volume":"32","author":"Rostamian M","year":"2023","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tig.2012.11.005","article-title":"The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis","volume":"29","author":"M\u00fcller B","year":"2013","journal-title":"Trends Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","article-title":"Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis","volume":"45","author":"Unissa AN","year":"2016","journal-title":"Infect Genet Evol"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119628","article-title":"Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review","volume":"10","author":"Seifert M","year":"2015","journal-title":"PloS one"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1038\/s41598-018-21378-x","article-title":"Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations","volume":"8","author":"Lempens P","year":"2018","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/AAC.01691-09","article-title":"Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis","volume":"54","author":"Ando H","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1128\/AAC.47.4.1241-1250.2003","article-title":"Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis","volume":"47","author":"Ramaswamy SV","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e02091","DOI":"10.1128\/AAC.02091-20","article-title":"Systematic review of mutations associated with isoniazid resistance points to continuing evolution and subsequent evasion of molecular detection, and potential for emergence of multidrug resistance in clinical strains of Mycobacterium tuberculosis","volume":"65","author":"Valafar SJ","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/MAJ.0b013e31825d32c6","article-title":"Multidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testing: a review of the literature","volume":"345","author":"Kalokhe AS","year":"2013","journal-title":"Am J Med Sci"},{"key":"ref13","article-title":"Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand","volume":"12","author":"Prommi A","year":"2024","journal-title":"Microbiol Spectr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jiph.2018.04.005","article-title":"Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis","volume":"11","author":"Zaw MT","year":"2018","journal-title":"J Infect Public Health"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jgar.2021.06.009","article-title":"Prevalence of drug resistance-conferring mutations associated with isoniazid- and rifampicin-resistant Mycobacterium tuberculosis in Ethiopia: a systematic review and meta-analysis","volume":"26","author":"Reta MA","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1967675","DOI":"10.1155\/2022\/1967675","article-title":"Frequency of rpoB, katG, and inhA gene polymorphisms associated with multidrug-resistant Mycobacterium tuberculosis complex isolates among Ethiopian TB patients: a systematic review","volume":"2022","author":"Seid A","year":"2022","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02400-24","article-title":"Mutations associated with resistance to rifampicin and isoniazid identified in strains of the Mycobacterium tuberculosis complex by GenoType MTBDRplus in Panama, 2015-2021","volume":"13","author":"Dom\u00ednguez Gonz\u00e1lez J","year":"2025","journal-title":"Microbiol Spectr"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"119701","DOI":"10.1016\/j.cca.2024.119701","article-title":"Multidrug-resistant tuberculosis","volume":"559","author":"Wulandari DA","year":"2024","journal-title":"Clin Chim Acta"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/JCM.00521-07","article-title":"Evaluation of the GenoType MTBDRplus assay for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens","volume":"45","author":"Hilleman D","year":"2007","journal-title":"J Clin Microbiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/JCM.01463-09","article-title":"Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology","volume":"48","author":"Helb D","year":"2010","journal-title":"J Clin Microbiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2217\/fmb.11.84","article-title":"Xpert MTB\/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance","volume":"6","author":"Lawn SD","year":"2011","journal-title":"Future Microbiol"},{"key":"ref22","series-title":"WHO treatment guidelines for isoniazid resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis","year":"2018"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5588\/ijtld.16.0716","article-title":"Isoniazid-resistant tuberculosis: a cause for concern?","volume":"21","author":"Stagg HR","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1128\/JCM.01904-15","article-title":"Multicenter evaluation of Anyplex Plus MTB\/NTM MDR-TB assay for rapid detection of Mycobacterium tuberculosis complex and multidrug-resistant isolates in pulmonary and extrapulmonary specimens","volume":"54","author":"Sali M","year":"2016","journal-title":"J Clin Microbiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s11033-020-05331-8","article-title":"Evaluation of Anyplex II MTB\/MDR kit's performance to rapidly detect isoniazid and rifampicin resistant Mycobacterium tuberculosis from various clinical specimens","volume":"47","author":"Chumpa N","year":"2020","journal-title":"Mol Biol Rep"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3855\/jidc.18026","article-title":"Molecular epidemiology and drug resistance of Mycobacterium tuberculosis in a tertiary care hospital in northeastern Mexico","volume":"17","author":"Flores-Ar\u00e9chiga A","year":"2023","journal-title":"J Infect Dev Ctries"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jinf.2015.03.011","article-title":"Diagnostic accuracy study of multiplex PCR for detecting tuberculosis drug resistance","volume":"71","author":"Molina-Moya B","year":"2015","journal-title":"J Infect"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.06418-11","article-title":"Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated in Nepal","volume":"56","author":"Poudel A","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/antibiotics14070732","article-title":"Genotypic and phenotypic methods in the detection of MDR-TB and evolution to XDR-TB","volume":"14","author":"Zaporojan N","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.21037\/jtd.2019.01.58","article-title":"Clinical implications of discrepant results between genotypic MTBDRplus and phenotypic Lowenstein-Jensen method for isoniazid or rifampicin drug susceptibility test in tuberculosis patients","volume":"11","author":"Kang JY","year":"2019","journal-title":"J Thorac Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/IDR.S242261","article-title":"Association between the phenotype and genotype of isoniazid resistance among Mycobacterium tuberculosis isolates in Thailand","volume":"13","author":"Charoenpak R","year":"2020","journal-title":"Infect Drug Resist"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/pathogens13010027","article-title":"Rapid diagnosis of drug-resistant tuberculosis: opportunities and challenges","volume":"13","author":"Naidoo K","year":"2023","journal-title":"Pathogens"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/AAC.05905-11","article-title":"Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing","volume":"56","author":"Streicher EM","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1128\/JCM.01691-15","article-title":"Comparison of three commercial molecular assays for detection of rifampin and isoniazid resistance among Mycobacterium tuberculosis isolates in a high-HIV-prevalence setting","volume":"53","author":"Strydom K","year":"2015","journal-title":"J Clin Microbiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.mimet.2017.05.006","article-title":"Diagnostic performance of Anyplex II MTB\/MDR\/XDR for detection of resistance to first and second line drugs in Mycobacterium tuberculosis","volume":"139","author":"P\u00e9rez-Garc\u00eda F","year":"2017","journal-title":"J Microbiol Methods"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.diagmicrobio.2017.08.016","article-title":"Laboratory evaluation of the Anyplex II MTB\/MDR and MTB\/XDR tests based on multiplex real-time PCR and melting-temperature analysis to identify Mycobacterium tuberculosis and drug resistance","volume":"89","author":"Igarashi Y","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00974-18","article-title":"Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests","volume":"62","author":"Kandler JL","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-024-00504-2","article-title":"Multidrug-resistant tuberculosis","volume":"10","author":"Dheda K","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"ref39","first-page":"001109","article-title":"Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh","volume":"9","author":"Lempens P","year":"2023","journal-title":"Microb Genom"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652026000100223&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T12:55:10Z","timestamp":1783083310000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652026000100223&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":39,"alternative-id":["S0036-46652026000100223"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202668040","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e40"}}